ANNUAL REPORT HOME ABOUT GENZYME SITEMAP LEGAL DISCLAIMER 
2006 Annual Report
Genzyme Logo
TABLE OF CONTENTS
Financial Highlights
Letter to Shareholders
Our Passion
Our Presence
Our Portfolio
Our Engine is Innovation
Renal Disease
Genetic Diseases
Orthopaedics/Biosurgical Specialties
Oncology/Endocrinology
Transplant/Immune Diseases
Genetics/Diagnostics
Our Pipeline
Our Commitment
Our Social Responsibility
Our Employees
2006 Annual Report Sitemap

Financial Highlights
        Summary of Operations
        Financial Position
Letter to Shareholders
        Continued Investment
        Rapid Myozyme Launch
        Optimizing Existing Products
        High-Impact Late-Stage Programs
        Commitment to Innovation
        A Clear Sense of Purpose
Our Passion
Our Presence
        Global Network
        Manufacturing and Distribution
        Clinical and Regulatory Affairs
Our Portfolio
        Genetics/Diagnostics
        Genetic Diseases
        Renal Disease
        Orthopaedics/Biosurgical Specialties
        Oncology/Endocrinology
        Transplant/Immune Diseases
Our Engine is Innovation
        Tolevamer
        Mozobil
        Alemtuzumab
Renal Disease
        Rapid Growth for Renagel Around The World
        Next-Generation Progress
        Chronic Kidney Disease
Genetic Diseases
        Myozyme Launched Worldwide
        Cerezyme: Available Around The World
        Fabrazyme: Driven by New Data
        Continued Progress and Investment
Orthopaedics/Biosurgical Specialties
        Continuing Leadership with Synvisc
        Innovation And Investment
        Sepra Products Developments
Oncology/Endocrinology
        Campath: Nearing First-Line Status
        Expanding Clolar to Adults
        Thyroid Cancer/Endocrinology
Transplant/Immune Diseases
        Thymoglobulin: Growing, Global
        Mozobil for Bone Marrow Transplantation
Genetics/Diagnostics
        Genzyme's Leadership
        Reproductive and Oncology Testing
        Diagnostic Products
Our Pipeline
        Genetics/Diagnostics Pipeline
        Product Development Pipeline
Our Commitment
Our Social Responsibility
        Access to Information and Therapy
        Supporting Global Health and Local Communities
Our Employees
        Individual Leadership
        Recognized for Excellence